Lumberton, Texas-based startup Ecoute Audio made a splash with its first-ever product back in 2023, when it unveiled its TH1 ...

Northwestern Medicine scientists have identified the cellular mechanisms that cause immune cells to differentiate and ultimately lose function during viral infection, findings that could improve ...

Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced that the independent Data ...

The tube stage uses a Korg Nutube 6P1 dual triode for voltage gain, supported by discrete Class A/B amplification per channel. This approach prioritizes harmonic structure, microdynamics, and spatial ...

Evommune surged 70% after EVO301's Phase 2a data showed rapid, significant EASI reductions in moderate-to-severe atopic ...

Immunovant, Inc. (NASDAQ:IMVT) Q3 2026 Earnings Call Transcript February 6, 2026 Immunovant, Inc. beats earnings expectations ...

Roivant reported third quarter fiscal 2025 financial results and highlighted new Phase 2 data for brepocitinib (BREPA) in ...

Subgroup analysis revealed a pronounced effect among patients receiving MAC. In this cohort, 6-month grade 2-4 GFS was 35.7% with placebo vs 60.7% with ustekinumab (OR 2.78 for failure; 80% CI, 1.19-6 ...

Detailed price information for Corvus Pharma Com (CRVS-Q) from The Globe and Mail including charting and trades.

Immunocompetence reflects the immune system’s capacity to mount effective responses against antigens. Cyclophosphamide (CYP), a chemotherapeutic and experimental immunosuppressive agent, disrupts ...

1 Division of Colorectal Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China 2 Neurology, Shanxi ...